Fexuprazan
Small moleculeexperimental
Clinical trial activity
29 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
17
Phase 2
9
Phase 3
8
Phase 4
1
Earliest trial started Mar 1, 2016 (NCT02757144)
Timeline
Indications
Approved for
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dwp14012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07144176 | Phase 1 | Sep 30, 2025 | Daewoong Pharmaceutical Co. LTD. |
| NCT06437951 | Phase 1 | Jul 31, 2024 | Daewoong Pharmaceutical Co. LTD., Seoul National University |
| NCT06751121 | Phase 3 | Feb 6, 2024 | Daewoong Pharmaceutical Co. LTD. |
| NCT06121830 | Phase 3 | Aug 31, 2023 | Daewoong Pharmaceutical Co. LTD. |
| NCT05946135 | Phase 4 | Jul 31, 2023 | Yonsei University |
| NCT05868967 | Phase 1 | Feb 27, 2023 | Beijing Boren Hospital, Daewoong Pharmaceutical Co. LTD., Shanghai Haini Pharmaceutical Co., Ltd. |
| NCT05812404 | Phase 1 | Oct 26, 2022 | Daewoong Pharmaceutical Co. LTD. |
| NCT05574374 | Phase 1 | Sep 21, 2022 | Daewoong Pharmaceutical Co. LTD. |
| NCT05304845 | Phase 1 | Mar 21, 2022 | Daewoong Pharmaceutical Co. LTD. |
| NCT06508645 | Phase 1 | Jan 10, 2022 | Daewoong Pharmaceutical Co. LTD., Seoul National University |
| NCT05813561 | Phase 3 | Dec 30, 2021 | Daewoong Pharmaceutical Co. LTD., Sun Yat-Sen University |
| NCT05149274 | Phase 1 | Oct 1, 2021 | Daewoong Pharmaceutical Co. LTD. |
| NCT04784910 | Phase 3 | Mar 31, 2021 | Daewoong Pharmaceutical Co. LTD. |
| NCT04888819 | N/A | Feb 1, 2021 | Daewoong Pharmaceutical Co. LTD., Konkuk University |
| NCT04827472 | Phase 1 | Jan 20, 2021 | Daewoong Pharmaceutical Co. LTD. |
| NCT04613895 | N/A | Nov 17, 2020 | Daewoong Pharmaceutical Co. LTD., Hanyang University |
| NCT04490434 | Phase 1 | Jun 19, 2020 | Daewoong Pharmaceutical Co. LTD., Seoul National University |
| NCT04328766 | Phase 1 | Jun 1, 2020 | Daewoong Pharmaceutical Co. LTD. |
| NCT04341428 | Phase 3 | May 30, 2020 | Daewoong Pharmaceutical Co. LTD. |
| NCT04341454 | Phase 3 | May 13, 2020 | Daewoong Pharmaceutical Co. LTD. |
Showing 20 of 29 trials
Page 1 / 2
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daewoong Pharmaceutical Co. LTD. | For profit | 28 | 27 | 4 | 2016 |
| Seoul National University | Academic/Hospital | 3 | 0 | 1 | 2020 |
| Beijing Boren Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Hanyang University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Konkuk University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Shanghai Haini Pharmaceutical Co., Ltd. | For profit | 1 | 0 | 1 | 2023 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Yonsei University | Academic/Hospital | 1 | 1 | 1 | 2023 |
8 organizations
Page 1 / 1